Community/Retail

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

This week, Suzanne Soliman, PharmD, BCMAS, is joined by guests Joanna Catravas, PharmD, BCMTMS, and Lisa Scholz, PharmD, MBA, FACHE, to discuss nontraditional roles for pharmacists.

Studies have estimated that 16% of people with dementia experience depression, but this may be as high as 40%, demonstrating a great need for effective treatments.

With climate change potentially affecting pollen counts, new OTC products can relieve symptoms.

Scientific abstracts also address findings on cardiovascular disease and population, the connection between COVID-19 and HF, and links between prognosis and marital status.

The advisory, published in Circulation, is a call to action for a cultural shift to identify and remove barriers.

Individuals with type 2 diabetes who use insulin are often restricted when accessing continuous glucose monitoring systems.

Larger increases were typically seen in states with fewer deaths related to COVID-19, lower unemployment among women, analysis finds.

Long-term extension trial results show a consistent safety profile and durable efficacy for the treatment of adults with the skin condition.

Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.

Phazyme is used to treat symptoms of gas, such as belching, bloating, and pressure in the stomach/gut.

With more than 80,000 retail and outpatient pharmacy locations, pharmacists are the most accessible health care professionals in the United States.

PQA is working on developing measures specifically for evaluating pharmacy performance measurement.

Serotonin syndrome generally occurs within 6 hours of a change in dose or addition of medication.

A significantly greater proportion or patients treated with either 15 or 30 mg show remission or endoscopic response or remission at week 52 compared with the placebo.

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis.

BC MAX Strength Fast Pain Relief Powders work fast to relieve tough headaches, body aches, aches and pains, and menstrual cramps.

Neil Lund, senior advisor, Avelere Health and Ryan Urgo, managing director, Health Policy, Avelere Health, discuss the impact of President Biden’s health care agenda on the pharmacy field.

The SDOH resource guide focuses on services specific to the pharmacy and pharmacists.

The results of a network analyses show that the elevated potential of contracting the virus is also linked to infliximab and tofacitinib, as well as several combination treatments.

Analysis also indicates that individuals with the highest-level beta-cryptoxanthin in their blood were less likely to develop cognitive issues decades later.

The recommendations apply to individuals who are already taking the maximum dose of statins.

Sara Wettergreen, assistant professor in the department of Clinical Pharmacy and Department of Family Medicine at Skaggs School of Pharmacy and Pharmaceutical Sciences, discusses burnout and mental health concerns among pharmacy technicians.

The combination of albuterol/budesonide shows promise in lowering the risk of severe exacerbations and improved lung function compared to albuterol as a rescue inhaler in patients with asthma.

Lifestyle-related factors, including food consumption, may significantly increase the chance of triggering a migraine headache.

Evidence suggests that there are many barriers to the proper implementation of MTM services, including time constraints and lack of staff support.

DenTek Instant Pain Relief helps soothe pain from toothaches, sore gums, and mouth sores.

The PQA team is diverse, and they have expertise in quantitative research as well as quality.

These measures are specified for application to pharmacies, as opposed to health plan measures.

Medications are the primary cause of acquired QT-prolongation, although the exact mechanism of why some people evoke torsades de pointes but others do not is still unknown.